-
1 Comment
Aequus Pharmaceuticals Inc is currently in a long term downtrend where the price is trading 21.1% below its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.
Aequus Pharmaceuticals Inc's total revenue rose by 66.9% to $619K since the same quarter in the previous year.
Its net income has increased by 61.9% to $-252K since the same quarter in the previous year.
Finally, its free cash flow grew by 81.1% to $-105K since the same quarter in the previous year.
Based on the above factors, Aequus Pharmaceuticals Inc gets an overall score of 4/5.
None
Here's how to backtest a trading strategy or backtest a portfolio for AQS.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
